President's Malaria Initiative E-Newsletter
December 2009
Table of Contents
News
Country-Specific Activities
Technical Areas
New and Updated Resources on PMI.gov
 News |
|
 |
|
 |
|
 |
|
| In Ethiopia, lab workers participate in training on drug quality testing using a low-tech, cost-effective portable laboratory. Sub-standard and counterfeit drugs are a significant health problem and contribute to the growth of resistant strains of malaria. Source: USAID/Ethiopia |
|
PMI Provides $40 Million Grant to Prevent and Treat Malaria
PMI announced a three-year, $40 million grant to the United Nations Children’s Fund to assist the Government of Ethiopia’s Federal Ministry of Health and the Oromia Regional Health Bureau in delivering appropriate malaria prevention, diagnosis, and treatment services. The program, called “Sustaining Malaria Reduction Interventions in Oromia,” will increase access to effective diagnostic tests and medicines to manage malaria cases and promote household ownership and proper use of long-lasting insecticide-treated nets (LLINs).
PMI Announces Community Grant Awards to Fight Malaria
PMI announced over $10.5 million in grants to seven organizations working in six countries in Africa to extend malaria prevention and control activities in communities most affected by the disease, particularly children under age 5 and pregnant women. "I am committed to expanding the work of nongovernmental and faith-based organizations, and other community-based entities to reach people with the tools and knowledge to control malaria," said R. Tim Ziemer, U.S. Global Malaria Coordinator. "The key to saving lives, especially children, is to expand proven approaches and interventions until they reach each and every child who needs them."
Grant Awarded to Ensure the Distribution and Proper Use of LLINs
A five-year $100 million grant was awarded to The Johns Hopkins Bloomberg School of Public Health's Center for Communication Programs, with the Malaria Consortium and Catholic Relief Services, to ensure the distribution and proper use of long-lasting insecticide-treated mosquito nets (LLINs) in malaria-endemic countries. USAID missions across Africa and in parts of Asia will be encouraged to buy into the project, including the 15 PMI focus countries.
New Request for Application to Conduct Research on the Use of IRS and LLINs for Malaria Vector Control – Due December 31, 2009
The purpose of this RFA is to solicit applications for funding from research institutions or organizations to carry out operations research to guide the combined and complementary use of indoor residual spraying (IRS) and LLINs for malaria vector control in PMI focus countries. The funds for the research are provided through PMI. This RFA describes the objectives of the research and provides information and instructions for applicants.
- Download the RFA [PDF, 116KB]
| Country-Specific Activities |
 |
|
|
|
|
The new FY10 Malaria Operational Plans (MOPs) for all 15 PMI focus countries are now available for download. Each MOP presents a detailed one-year implementation plan for PMI in each designated country and includes a brief review of the current status of malaria control and prevention policies and interventions, identifies challenges and unmet needs if the goals of PMI are to be achieved, and provides a description of planned activities for PMI. New PMI Contracts and Agreements Recent PMI contracts and agreements include:
|
| Technical Areas |
|
|
|
|
|
News from the Field
 |
|
| Shakira holds her teddy bear and stands with her friends and family after being treated and cured of malaria.
Read the full story. Source: The MENTOR Initiative |
|
Read new success stories about some of PMI’s most effective strategies, including IRS, artemisinin-based combination therapies (ACTs), and insecticide-treated mosquito nets.
- Angola: Angola Pilots Private Sector Distribution of ACTs
Since 2006, Coartem® – an ACT – has been procured by PMI for distribution in Angola via the public sector. Routine support visits show that staff at more than 60 percent of health facilities are using the new ACT protocol for uncomplicated malaria.
- Ethiopia: A PMI-Supported Surveillance System Established in Ethiopia to Monitor the Quality of Antimalarial Drugs
A recent round of PMI-supported post-marketing surveillance of antimalarials in a region of Ethiopia found that the private market is rife with products that are not approved for the treatment of uncomplicated malaria, including artemisinin monotherapies and sulfadoxine-pyrimethamine.
| New and Updated Resources on PMI.gov |
|
|
|
|
|
New Photo Gallery: PMI Supports Strengthening of Supply Chain Systems to Get Commodities Where They Are Needed
To ensure adequate stocks of antimalarial drugs and other commodities, PMI works with National Malaria Control Programs to strengthen each link in their supply chain, from selection of the appropriate products to monitoring stocks on shelves in rural health clinics.
 |
 |
 |
 |
 |
 |
If you have questions or comments, please contact Chris Thomas at ChThomas@usaid.gov.
Read the archived editions of PMI E-News
To ensure delivery of this e-newsletter to your inbox, please add pmi@aimglobalhealth.org to your e-mail address book or safe senders list.
Subscribe | Unsubscribe | Update Your E-mail Address | Other USAID E-Newsletters | Privacy Policy
If you have questions or problems with the subscription service, please contact support@govdelivery.com